
09/02/2025
The Frederick National Laboratory continues to make impactful contributions to lung through scientific discoveries and collaborations that are shaping the future of cancer treatment. Explore our recent discoveries:
⭐️ RAS drug discovery at FNL reaches lung cancer patients in a clinical trial: https://heyor.ca/gCf1up
⭐️ Controlling blood sugar may improve outcomes for diabetic lung cancer patients: https://heyor.ca/fMHOzH
⭐️ CDK2 inhibition may have potential for treating lung and other cancers: https://heyor.ca/W2fpbC
An investigational treatment co-discovered by RAS Initiative scientists at the Frederick National Laboratory (FNL) is now being tested in patients with advanced non-small cell lung cancer driven by mutant KRAS G12C.